Pharming Group N.V. presents its (unaudited) financial report for the first quarter of the year ended 31 March 2021.
As previously experienced, the progression of the COVID-19 pandemic has resulted in quarterly fluctuations in revenue. Results in Q1 2021 were negatively affected in the US by a severe COVID-19 surge at the end of 2020 and into 2021
- Sijmen de Vries - CEOAttachments
- Original document
- Permalink
Disclaimer
Pharming Group NV published this content on 13 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 May 2021 08:11:07 UTC.